Vimarsana
Biggest News Aggregation in the World

Page 27 - Global Yield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Yield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Yield Today - Breaking & Trending Today

Newscall Presswire: Recast1 Secures $15 Million Capital Commitment from Global Emerging Markets (GEM) - Vimarsana News

Newscall Presswire: Recast1 Secures $15 Million Capital Commitment from Global Emerging Markets (GEM)

London, United Kingdom--(Newsfile Corp. - April 25, 2022) - GEM Global Yield LLC SCS ("GGY"), the Luxembourg-based vehicle that is part of the GEM Group, made a $15 million capital commitment to Recast1

Biliti Electric plans to invest around Rs 1144 crore to set up EV 3 wheeler plant in Telangana - Vimarsana News

Biliti Electric plans to invest around Rs 1144 crore to set up EV 3 wheeler plant in Telangana

Biliti Motors, Biliti Electric, Hyderabad, Gayam Motor Works, GMW, EV 3 wheeler, Telangana

Biliti Electric to Setup the World's Largest Electric Three-Wheeler Manufacturing Facility in India's Telangana State - Vimarsana News

Biliti Electric to Setup the World's Largest Electric Three-Wheeler Manufacturing Facility in India's Telangana State

/PRNewswire/ -- California-based Biliti Electric Inc (Biliti) announced that it intends to setup the world's largest electric three-wheeler factory in India's...

Biliti lines up $150 mn to set up electric three-wheeler facility in Telangana - Vimarsana News

Biliti lines up $150 mn to set up electric three-wheeler facility in Telangana

Biliti lines up $150 mn to set up electric three-wheeler facility in Telangana

Gastrointestinal Biotech Company Renexxion Ireland Announces $100M Investment Commitment - Vimarsana News

Gastrointestinal Biotech Company Renexxion Ireland Announces $100M Investment Commitment

/PRNewswire/ -- Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need in...